Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Short-Term Debt : €8.1 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Short-Term Debt?

Laboratorios Farmaceuticos Rovi's Short-Term Debt for the quarter that ended in Dec. 2023 was €8.1 Mil.

Laboratorios Farmaceuticos Rovi's quarterly Short-Term Debt stayed the same from Jun. 2023 (€0.0 Mil) to Sep. 2023 (€0.0 Mil) but then increased from Sep. 2023 (€0.0 Mil) to Dec. 2023 (€8.1 Mil).

Laboratorios Farmaceuticos Rovi's annual Short-Term Debt increased from Dec. 2021 (€3.0 Mil) to Dec. 2022 (€8.2 Mil) but then declined from Dec. 2022 (€8.2 Mil) to Dec. 2023 (€8.1 Mil).

Laboratorios Farmaceuticos Rovi Short-Term Debt Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Short-Term Debt Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

9.11

2.03

2.96

8.24

8.06

Laboratorios Farmaceuticos Rovi Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	8.06	-

Laboratorios Farmaceuticos Rovi Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Laboratorios Farmaceuticos Rovi Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 41L:Germany

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.